Fig. 2From: Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patientsExpression of genes defining molecular subtypes. Paired gene expression fold-changes of genes defining molecular subtypes at the time of progression compared to before initiation of bevacizumab therapy in responding patients. ● indicates the gene expression change according to the 25% percentile of subtype genes. * Modified Phillips classifier used on the AVAglio datasetBack to article page